Newborn Bleeding Risk Rises Sharply

The rate of U.S. parents and caregivers declining the standard vitamin K shot for newborns has surged dramatically in 2026, heightening the risk of severe, life-threatening bleeding in infants. Analysis of over one million births revealed a 57% jump in non-administration of the vitamin K shot from January to June.

This acceleration is more than double the rate seen in previous years, with the non-administration rate in the first half of 2026 being 2.5 times higher than the 2019-2024 average. Infants are born with critically low vitamin K levels, essential for blood clotting, and remain vulnerable until around six months of age.

Without the injection, babies face an 81-fold increased risk of bleeding in the brain or gut during their first six months. One in five infants experiencing such severe bleeding tragically dies. Pediatricians are alarmed by this trend, viewing it as a concerning step backward in infant healthcare.

This increase in vitamin K refusals correlates with growing mistrust in routine newborn interventions, partly fueled by public health messaging that casts doubt on vaccines and established medical practices. Concerns about vitamin K and declining trust in public health institutions predate the current administration and grew significantly during the COVID-19 pandemic.

Nationally, the percentage of infants not receiving vitamin K at birth reached 8.1% by the end of June 2026. Medical professionals are now administering the shot in outpatient clinics due to its prevalence. Studies indicate female infants are disproportionately affected, facing twice the risk of vitamin K refusal compared to male infants.